RNUGF (ReNeuron Group) Total Stockholders Equity : $3.00 Mil (As of Sep. 2023)

View and export this data going back to 2006. Start your Free Trial

What is ReNeuron Group Total Stockholders Equity?

ReNeuron Group's Total Stockholders Equity for the quarter that ended in Sep. 2023 was $3.00 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. ReNeuron Group's Book Value per Share for the quarter that ended in Sep. 2023 was $0.05. The ratio of a company's debt over equity can be used to measure how leveraged this company is. ReNeuron Group's Debt-to-Equity for the quarter that ended in Sep. 2023 was 0.14.

ReNeuron Group Total Stockholders Equity Historical Data

The historical data trend for ReNeuron Group's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ReNeuron Group Total Stockholders Equity Chart

ReNeuron Group Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Total Stockholders Equity

Get a 7-Day Free Trial

30.63

16.37

26.22

13.03

6.14

ReNeuron Group Semi-Annual Data
	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Total Stockholders Equity	Get a 7-Day Free Trial															19.44	13.03	8.02	6.14	3.00

ReNeuron Group (OTCPK:RNUGF) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

ReNeuron Group's Book Value per Share for the quarter that ended in Sep. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(2.996	-	0)	/	57.174
	=	0.05

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

ReNeuron Group's Debt-to-Equity for the quarter that ended in Sep. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.193	+	0.234)	/	2.996
	=	0.14

ReNeuron Group Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of ReNeuron Group's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

ReNeuron Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ReNeuron Group PLC (OTCPK:RNUGF) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

Pencoed Business Park, Pencoed, Bridgend, GBR, CF35 5HY

Website

https://www.reneuron.com

ReNeuron Group PLC is engaged in the field of biotechnology. Its core activities include the research and clinical development of cell-based therapeutics. The company product pipeline includes the human retinal progenitor cell line (hRPC) and CTX neural cell line. It derives revenue from UK and U.S. The company is mainly focusing on the treatment of stroke disability, inherited retinal diseases, and cancer.